Expression of urotensin-II in human coronary atherosclerosis

This publication has 31 references indexed in Scilit:

• Cellular distribution of immunoreactive urotensin-II in human tissues with evidence of increased expression in atherosclerosis and a greater constrictor response of small compared to large coronary arteries
  Peptides, 2004
• Increased plasma urotensin II levels in patients with diabetes mellitus
  Clinical Science, 2003
• Human urotensin II increases coronary perfusion pressure in the isolated rat heart: Potentiation by nitric oxide synthase and cyclooxygenase inhibition
  Life Sciences, 2001
• Inhibition of Insulin Release by Urotensin II - A Study on the Perfused Rat Pancreas
  Hormone and Metabolic Research, 2001
• Role of Endothelin‐1 in Atherosclerosis^a
  Annals of the New York Academy of Sciences, 2000
• Nitric oxide activity in the human coronary circulation. Impact of risk factors for coronary atherosclerosis.
  Journal of Clinical Investigation, 1995
• Physiologic consequences of increased vascular oxidant stresses in hypercholesterolemia and atherosclerosis: Implications for impaired vasomotion
  The American Journal of Cardiology, 1995
• The pathogenesis of atherosclerosis: a perspective for the 1990s
  Nature, 1993
• The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
  New England Journal of Medicine, 1992
• Effects of somatostatin-25 and urotensin II on lipid and carbohydrate metabolism of coho salmon, Oncorhynchus kisutch
  General and Comparative Endocrinology, 1987